Trait anxiety and glucose metabolism in people without diabetes: Vulnerabilities among black women

Diabetic Medicine

Volumn 29, Issue 6, 2012, Pages 803-806

  Tsenkova, V K ^a   Albert, M A ^b   Georgiades, A ^c   Ryff, C D ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anxiety; Black ethnicity; Glucose metabolism; Non diabetic women

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AFRICAN AMERICAN; ANXIETY; ARTICLE; DEPRESSION; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; INCOME; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PSYCHOSOCIAL ENVIRONMENT; RACE; SEX DIFFERENCE;

AFRICAN AMERICANS; ANXIETY; BLOOD GLUCOSE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION; UNITED STATES;

EID: 84861155480     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.3534.x     Document Type: Article

References (25)

1. Lustman PJ, Penckofer SM, Clouse RE. Recent advances in understanding depression in adults with diabetes. Curr Diab Rep 2007; 7: 114-122.
2. Carnethon MR, Kinder LS, Fair JM, Stafford RS, Fortmann SP. Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971-1992. Am J Epidemiol 2003; 158: 416-423.
3. Lloyd CE. Diabetes and mental health; the problem of co-morbidity. Diabet Med 27: 853-854.
4. Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 2005; 161: 652-660.
5. Skinner TC, Carey ME, Cradock S, Dallosso HM, Daly H, Davies MJ et al. Depressive symptoms in the first year from diagnosis of Type 2 diabetes: results from the DESMOND trial. Diabet Med 27: 965-967.
6. Li C, Barker L, Ford ES, Zhang X, Strine TW, Mokdad AH. Diabetes and anxiety in US adults: findings from the 2006 Behavioral Risk Factor Surveillance System. Diabet Med 2008; 25: 878-881.
7. Anderson RJ, Grigsby AB, Freedland KE, de Groot M, McGill JB, Clouse RE et al. Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med 2002; 32: 235-247.
8. Suarez EC. Sex differences in the relation of depressive symptoms, hostility, and anger expression to indices of glucose metabolism in nondiabetic adults. Health Psychol 2006; 25: 484-492.
9. Everson-Rose SA, Meyer PM, Powell LH, Pandey D, Torrens JI, Kravitz HM et al. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 2004; 27: 2856-2862.
10. Surwit RS, Williams RB, Siegler IC, Lane JD, Helms M, Applegate KL et al. Hostility, race, and glucose metabolism in nondiabetic individuals. Diabetes Care 2002; 25: 835-839.
11. Georgiades A, Lane JD, Boyle SH, Brummett BH, Barefoot JC, Kuhn CM et al. Hostility and fasting glucose in African American women. Psychosom Med 2009; 71: 642-645.
12. Kessler RC, Gruber M, Hettema JM, Hwang I, Sampson N, Yonkers KA. Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up. Psychol Med 2008; 38: 365-374.
13. Love GD, Seeman TE, Weinstein M, Ryff CD. Bioindicators in the MIDUS National Study: protocol, measures, sample, and comparative context. J Aging Health 2010; 22: 1059-1080.
14. Radler BT, Ryff CD. Who Participates? Accounting for Longitudinal Retention in the MIDUS National Study of Health and Well-Being. J Aging Health 22: 307-331.
15. Spielberger CD. Manual for the State-Trait Anxiety Inventory (Form Y) ('Self-Evaluation Questionnaire'). Palo Alto: Consulting Psychologists Press, 1983.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
17. Radloff L. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
18. Surwit RS, Williams RB, Lane JD, Feinglos MN, Kuhn CM, Georgiades A. Plasma epinephrine predicts fasting glucose in centrally obese African-American women. Obesity (Silver Spring) 2010; 18: 1683-1687.
19. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 2000; 283: 2253-2259.
20. Narita K, Murata T, Hamada T, Kosaka H, Sudo S, Mizukami K et al. Associations between trait anxiety, insulin resistance and atherosclerosis in the elderly: a pilot cross-sectional study. Psychoneuroendocrinology 2008; 33: 305-312.
21. McConnaughey MM, Sheets KA, Davis J, Privette J, Hickner R, Christian B et al. Differences in beta-adrenergic receptor densities in omental and subcutaneous adipose tissue from obese African American and Caucasian women. Metabolism 2004; 53: 247-251.
22. Miller DB, O'Callaghan JP. Neuroendocrine aspects of the response to stress. Metabolism 2002; 51: 5-10.
23. Black PH, Garbutt LD. Stress, inflammation and cardiovascular disease. J Psychosom Res 2002; 52: 1-23.
24. Gum AM, King-Kallimanis B, Kohn R. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication. Am J Geriatr Psychiatry 2009; 17: 769-781.
25. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19.